Research

Mixed

Bariatric surgery (gastric bypass, sleeve gastrectomy, or adjustable gastric banding) is cost-effective over a 10-year horizon and cost-saving over a lifetime compared to conventional medical management, primarily by reducing the incidence of type 2 diabetes and cardiovascular events.

For obese individuals with BMI >40 (or >35 with Type 2 Diabetes) who have failed conservative weight loss, bariatric surgery is a clinically and economically superior long-term strategy compared to medical management alone. It significantly reduces the risk of diabetes and cardiovascular disease, leading to cost savings and improved quality of life over a lifetime. However, access barriers like insurance restrictions and waiting lists should be minimized, as delays result in lost health benefits.

GoodSupportsHIGH confidence
Over 10 years, bariatric surgery led to the incremental cost of €2909, generated additional 0.03 years of life and 1.2 quality-adjusted life years (QALYs). Bariatric surgery was cost-effective at 10 years with an incremental cost-effectiveness ratio of €2457 per QALY. Over a lifetime, surgery led to savings of €8522 and generated an increment of 0.7 years of life or 3.2 QALYs.
Oleg Borisenko et al. · BMC Surgery · 2017

Why this rating

Decision analytic modeling based on registry data and literature; validated against external studies, but not a primary RCT.

Source

Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling

Oleg Borisenko et al. · BMC Surgery · 2017

DOI 10.1186/s12893-017-0284-0

unknownCited 27×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →